The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx
Inflammatory diseases of the pharynx constitute one of the most significant nosologies groups in the ENT organ diseases profile. According to modern epidemiological data, acute and chronic tonsillopharyngitis are inferior only to influenza and other forms of ARVI with predominantly nasal and paranas...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2772 |
_version_ | 1827962366829002752 |
---|---|
author | S. V. Ryazantsev D. D. Kalyapin |
author_facet | S. V. Ryazantsev D. D. Kalyapin |
author_sort | S. V. Ryazantsev |
collection | DOAJ |
description | Inflammatory diseases of the pharynx constitute one of the most significant nosologies groups in the ENT organ diseases profile. According to modern epidemiological data, acute and chronic tonsillopharyngitis are inferior only to influenza and other forms of ARVI with predominantly nasal and paranasal sinuses, as well as the lower respiratory tract inflammation in prevalence among the population. Infectious pathogens are the most common etiology of inflammatory diseases of the pharynx. Accordingly, the pharmacological agents should be selected among the drugs having pronounced antimicrobial activity against both bacterial and other organisms - viral and fungal, and an analgesic effect, as sore throat is the main symptom of tonsillofingitis. The combination preparation Septolete® total is one of such drugs. |
first_indexed | 2024-04-09T16:40:55Z |
format | Article |
id | doaj.art-9c3bd021f2204d8d9f16a21e899512b3 |
institution | Directory Open Access Journal |
issn | 2079-701X 2658-5790 |
language | Russian |
last_indexed | 2024-04-09T16:40:55Z |
publishDate | 2018-11-01 |
publisher | Remedium Group LLC |
record_format | Article |
series | Медицинский совет |
spelling | doaj.art-9c3bd021f2204d8d9f16a21e899512b32023-04-23T06:56:41ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-11-01020555710.21518/2079-701X-2018-20-55-572714The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynxS. V. Ryazantsev0D. D. Kalyapin1Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. PetersburgSaint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. PetersburgInflammatory diseases of the pharynx constitute one of the most significant nosologies groups in the ENT organ diseases profile. According to modern epidemiological data, acute and chronic tonsillopharyngitis are inferior only to influenza and other forms of ARVI with predominantly nasal and paranasal sinuses, as well as the lower respiratory tract inflammation in prevalence among the population. Infectious pathogens are the most common etiology of inflammatory diseases of the pharynx. Accordingly, the pharmacological agents should be selected among the drugs having pronounced antimicrobial activity against both bacterial and other organisms - viral and fungal, and an analgesic effect, as sore throat is the main symptom of tonsillofingitis. The combination preparation Septolete® total is one of such drugs.https://www.med-sovet.pro/jour/article/view/2772inflammatory diseases of the pharynxlocal antisepticsseptolete® total |
spellingShingle | S. V. Ryazantsev D. D. Kalyapin The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx Медицинский совет inflammatory diseases of the pharynx local antiseptics septolete® total |
title | The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx |
title_full | The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx |
title_fullStr | The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx |
title_full_unstemmed | The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx |
title_short | The next-generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx |
title_sort | next generation combination drugs as part of the comprehensive therapy for inflammatory diseases of the pharynx |
topic | inflammatory diseases of the pharynx local antiseptics septolete® total |
url | https://www.med-sovet.pro/jour/article/view/2772 |
work_keys_str_mv | AT svryazantsev thenextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx AT ddkalyapin thenextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx AT svryazantsev nextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx AT ddkalyapin nextgenerationcombinationdrugsaspartofthecomprehensivetherapyforinflammatorydiseasesofthepharynx |